🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size
60 Servings
Non-Nutrient/Non-Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Kre-Alkalyn
1500 mg

Other Ingredients

Maltodextrin Magnesium Stearate Gelatin Titanium Dioxide FD&C Red # 40 FD & C Blue #1

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (93% of products) Nutrient (20% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take 2 capsules with 12 ounces of water once daily. For best results, consume at least 64 ounces of water throughout the day.

⚠️ Warnings & Precautions

Protect from heat, light, and moisture.

Keep out of reach of children.

🧪 Formulation Notes

No Banned Substances Steroid-Free

Additional Information

Certified cGMP

Current Good Manufacturing Practices

** In 2006, 24 healthy men from the Bulgarian National Weight Lifting Team increased their weight lift totals by 28.25%

Stroychev, Kamen., N. Terziiski (2006). Comparison of Kre-Alkalyn to Creatine on body composition, muscular performance, & safety. Dr. I.S. Greenberg Medical Center, Sofia, Bulgaria.

Patented Formula

Alkaline pH Formula

Keep lid tightly closed in a cool, dry place.

Questions or Comments? Call 1-800-832-9948

Product Details

UPC / SKU 7 10779 33351 2
DSLD Entry Date 2016-07-25
Product Type Non-Nutrient/Non-Botanical
Form Capsule
DSLD ID 62521
Data Updated 2026-04-11

Research Evidence

739 Research Sources
47 Avg Quality Score
472 Clinical Trial
139 Meta Analysis
74 Systematic Review
47 Rct
2 Regulatory Source
1 Cochrane Review
1 Guideline
1 Openfda Safety
A Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data
Meta Analysis JAMA psychiatry 2021
A HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
Meta Analysis The Cochrane database of systematic reviews 2014
A Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease
Meta Analysis The Cochrane database of systematic reviews 2014
B Greater Choline-Containing Compounds and Myo-inositol in Treatment-Resistant Versus Responsive Schizophrenia: A 1H-Magnetic Resonance Spectroscopy Meta-analysis
Meta Analysis Biological psychiatry. Cognitive neuroscience and neuroimaging 2024
B Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
Systematic Review BMC medicine 2019
B Efficacy of Creatine Supplementation Combined with Resistance Training on Muscle Strength and Muscle Mass in Older Females: A Systematic Review and Meta-Analysis
Meta Analysis Nutrients 2021
B The Effects of Creatine Supplementation on Upper- and Lower-Body Strength and Power: A Systematic Review and Meta-Analysis
Meta Analysis Nutrients 2025
B Meta-analysis of the efficacy and safety of Finerenone in diabetic kidney disease
Meta Analysis Medicine 2026
B Creatine and creatine analogues in hypertension and cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2011
B HMG CoA reductase inhibitors (statins) for dialysis patients
Meta Analysis The Cochrane database of systematic reviews 2013
View all evidence for Creatine →

Compare Similar Products

View all Creatine products →